{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "AbbVie", "item": "https://www.patentleaderboard.com/company/abbvie"}, {"@type": "ListItem", "position": 3, "name": "Eric Beusoleil", "item": "https://www.patentleaderboard.com/inventor/fl:er_ln:beusoleil-1"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
EB

Eric Beusoleil — 3 Patents

AbbVie: 3 patents #535 of 1,308Top 45%
ESExonhit Therapeutics, Sa: 2 patents #13 of 30Top 45%
Paris, FR: #3,135 of 13,709 inventorsTop 25%
Overall (All Time): #1,328,092 of 4,157,543Top 35%
3 Patents All Time
Eric Beusoleil has been granted 3 US patents while listed as an inventor at AbbVie. The first was granted in 2013 and the most recent in November 2017. Eric Beusoleil ranks #1,328,092 of 4,157,543 US inventors in our database (top 31.9%). Patent records list Eric Beusoleil in Paris, FR.

Patents per Year

Patents granted per year, 2013 to 2017Bar chart with a peak of 1 patents in 2013.peak 12013: 1 patents20132016: 1 patents20162017: 1 patents2017

Issued Patents All Time

Showing 1–3 of 3 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
9828349 1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds having analgesic and/or immuno stimulant activity Bertrand Leblond, Thierry Taverne, John E. Donello 2017-11-28
9399628 1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds having analgesic and/or immuno stimulant activity Bertrand Leblond, Thierry Taverne, John E. Donello 2016-07-26
8513288 1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds having analgesic and/or immuno stimulant activity Bertrand Leblond, Thierry Taverne, John E. Donello 2013-08-20 $16,561,000